France· FR:65579730
PAXLOVID 150 mg + 100 mg, comprimé pelliculé
A medicinal product containing nirmatrelvir + ritonavir, registered in France by PFIZER EUROPE MA EEIG (BELGIQUE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- NIRMATRELVIR + RITONAVIR
- Manufacturer
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930245514plaquette(s) OPA : polyamide orienté aluminium PVC de 30 (20 + 10) comprimésEUR 999.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nirmatrelvir + ritonavir in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPAXLOVIDPfizer Europe MA EEIG, Bruxelles
- NorwayPaxlovidPfizer Europe MA EEIG
- CanadaPAXLOVIDPFIZER CANADA ULC
- FinlandPaxlovidPfizer Europe MA EEIG
- IcelandPaxlovidPfizer Europe MA EEIG*
- NetherlandsPaxlovid 150 mg filmomhulde tabletten (PF-12345678) en 100 mg filmomhulde tabletten (ritonavir)Pfizer Europe MA EEIG
- PolandPaxlovidPfizer Europe MA EEIG
- SwedenPaxlovid 150 mg + 100 mg Filmdragerad tablettPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Paxlovid
- Liechtenstein · Paxlovid
- Norway · Paxlovid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cfd19ed3-dc78-4045-9760-391ed1e5b1e0 GET /v1/drugs/cfd19ed3-dc78-4045-9760-391ed1e5b1e0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65579730",
"date_amm": "2022-01-28",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/22/1625",
"substance": "NIRMATRELVIR + RITONAVIR",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé et comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about nirmatrelvir + ritonavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.